English | Español

Technology/Innovation
+ Technology/Innovation
Jamie Barrand | Dec 27, 2015

New diabetes therapy receives final FDA approval
Jamie Barrand | Dec 27, 2015

AstraZeneca acquires majority stake in Acerta Pharma
+ Technology/Innovation
Jamie Barrand | Dec 24, 2015

AHA names two injectable PCSK9 inhibitors among 2015's top research advances
+ Technology/Innovation
Jamie Barrand | Dec 24, 2015

Merck, Pfizer launch phase III trial of ovarian cancer therapy
+ Technology/Innovation
Jamie Barrand | Dec 24, 2015

New study links GABA activity to severity of autism symptoms
+ Technology/Innovation
Jamie Barrand | Dec 24, 2015

AstraZeneca releases preliminary results from lung cancer drug's clinical trial
+ Community
Jamie Barrand | Dec 24, 2015

FTA funds National Aging and Disability Transportation Center, improves accessibility
+ Regulatory
Jamie Barrand | Dec 24, 2015

The AIDS Institute officials laud rejection of HIV funding cuts

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes